Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jul 17, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special physical activity program designed for women who are currently being treated for breast cancer. The program is called Adapted Physical Activity (APA) and has been recognized as a helpful non-drug therapy. The researchers believe that participating in this program may improve the quality of life for women undergoing treatment and could also lower health care costs. They will compare this standardized APA program to regular recommendations for physical activity to see which is more effective during cancer treatment.
To participate in this trial, women must have any type of breast cancer and be receiving treatment, which could include surgery, chemotherapy, radiation, or hormone therapy. However, there are some health conditions that would prevent someone from joining, such as severe heart or lung problems, recent surgery, or extreme fatigue. The trial is not yet recruiting participants, but women who meet the eligibility criteria can expect to be part of a study that aims to explore how physical activity can support their health during treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women with breast cancer
- • any type of breast cancer, all grades, all stages
- • during treatment: surgery +/- chemotherapy +/- radiotherapy +/- hormone therapy
- Exclusion Criteria:
- • World Health Organization (WHO) 4
- • Unstable angina
- • Uncontrolled Atrial fibrillation
- • Uncontrolled high blood pressure
- • Recent myocardial infarction or myocarditis or pericarditis or thromboembolic disease (less than 3 weeks)
- • Aortic stenosis or valve disease to operate
- • Cardiac or respiratory failure, with dyspnea at rest
- • Symptomatic anemia, thrombocytopenia
- • Lytic or painful bone metastases, Severe osteoporosis
- • Severe infectious syndrome,
- • Surgery in the last 3 weeks
- • Extreme fatigue, sharp pain, dizziness, disturbance of consciousness, severe undernutrition
- • Contraindication to the practice of an adapted physical activity programme
- • Currently involved or exclusion period of a interventional study or adapted Physical Activity program
- • Patient with protective measures (guardianship, curators, and deprivation of liberty).
- • Pregnancy or breastfeeding
- • Patient with severe functional limitations
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
Marie-Eve Rougé-Bugat, MD
Principal Investigator
University Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported